Skip to main content
Journal cover image

Comparative study of PRPH2 D2 loop mutants reveals divergent disease mechanism in rods and cones.

Publication ,  Journal Article
Ikelle, L; Makia, M; Lewis, T; Crane, R; Kakakhel, M; Conley, SM; Birtley, JR; Arshavsky, VY; Al-Ubaidi, MR; Naash, MI
Published in: Cell Mol Life Sci
July 19, 2023

Mutations in the photoreceptor-specific tetraspanin gene peripherin-2 (PRPH2) lead to widely varying forms of retinal degeneration ranging from retinitis pigmentosa to macular dystrophy. Both inter- and intra-familial phenotypic heterogeneity has led to much interest in uncovering the complex pathogenic mechanisms of PRPH2-associated disease. Majority of disease-causing mutations in PRPH2 reside in the second intradiscal loop, wherein seven cysteines control protein folding and oligomerization. Here, we utilize knockin models to evaluate the role of three D2 loop cysteine mutants (Y141C, C213Y and C150S), alone or in combination. We elucidated how these mutations affect PRPH2 properties, including oligomerization and subcellular localization, and contribute to disease processes. Results from our structural, functional and molecular studies revealed that, in contrast to our understanding from prior investigations, rods are highly affected by PRPH2 mutations interfering with oligomerization and not merely by the haploinsufficiency associated with these mutations. On the other hand, cones are less affected by the toxicity of the mutant protein and significantly reduced protein levels, suggesting that knockdown therapeutic strategies may sustain cone functionality for a longer period. This observation provides useful data to guide and simplify the current development of effective therapeutic approaches for PRPH2-associated diseases that combine knockdown with high levels of gene supplementation needed to generate prolonged rod improvement.

Duke Scholars

Published In

Cell Mol Life Sci

DOI

EISSN

1420-9071

Publication Date

July 19, 2023

Volume

80

Issue

8

Start / End Page

214

Location

Switzerland

Related Subject Headings

  • Tetraspanins
  • Retinitis Pigmentosa
  • Retinal Degeneration
  • Retinal Cone Photoreceptor Cells
  • Mutation
  • Macular Degeneration
  • Humans
  • Biochemistry & Molecular Biology
  • 3211 Oncology and carcinogenesis
  • 3205 Medical biochemistry and metabolomics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ikelle, L., Makia, M., Lewis, T., Crane, R., Kakakhel, M., Conley, S. M., … Naash, M. I. (2023). Comparative study of PRPH2 D2 loop mutants reveals divergent disease mechanism in rods and cones. Cell Mol Life Sci, 80(8), 214. https://doi.org/10.1007/s00018-023-04851-3
Ikelle, Larissa, Mustafa Makia, Tylor Lewis, Ryan Crane, Mashal Kakakhel, Shannon M. Conley, James R. Birtley, Vadim Y. Arshavsky, Muayyad R. Al-Ubaidi, and Muna I. Naash. “Comparative study of PRPH2 D2 loop mutants reveals divergent disease mechanism in rods and cones.Cell Mol Life Sci 80, no. 8 (July 19, 2023): 214. https://doi.org/10.1007/s00018-023-04851-3.
Ikelle L, Makia M, Lewis T, Crane R, Kakakhel M, Conley SM, et al. Comparative study of PRPH2 D2 loop mutants reveals divergent disease mechanism in rods and cones. Cell Mol Life Sci. 2023 Jul 19;80(8):214.
Ikelle, Larissa, et al. “Comparative study of PRPH2 D2 loop mutants reveals divergent disease mechanism in rods and cones.Cell Mol Life Sci, vol. 80, no. 8, July 2023, p. 214. Pubmed, doi:10.1007/s00018-023-04851-3.
Ikelle L, Makia M, Lewis T, Crane R, Kakakhel M, Conley SM, Birtley JR, Arshavsky VY, Al-Ubaidi MR, Naash MI. Comparative study of PRPH2 D2 loop mutants reveals divergent disease mechanism in rods and cones. Cell Mol Life Sci. 2023 Jul 19;80(8):214.
Journal cover image

Published In

Cell Mol Life Sci

DOI

EISSN

1420-9071

Publication Date

July 19, 2023

Volume

80

Issue

8

Start / End Page

214

Location

Switzerland

Related Subject Headings

  • Tetraspanins
  • Retinitis Pigmentosa
  • Retinal Degeneration
  • Retinal Cone Photoreceptor Cells
  • Mutation
  • Macular Degeneration
  • Humans
  • Biochemistry & Molecular Biology
  • 3211 Oncology and carcinogenesis
  • 3205 Medical biochemistry and metabolomics